AR022685A1 - Uso de estimulantes de factores neurotroficos para el tratamiento de enfermedades neurodegenerativas oftalmicas. - Google Patents
Uso de estimulantes de factores neurotroficos para el tratamiento de enfermedades neurodegenerativas oftalmicas.Info
- Publication number
- AR022685A1 AR022685A1 ARP990106130A ARP990106130A AR022685A1 AR 022685 A1 AR022685 A1 AR 022685A1 AR P990106130 A ARP990106130 A AR P990106130A AR P990106130 A ARP990106130 A AR P990106130A AR 022685 A1 AR022685 A1 AR 022685A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- stimulants
- neurodegenerative diseases
- neurotrophic factors
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Composiciones y métodos para el tratamiento de una neuropatía en la cabeza del nervio optico y la retina. Las composiciones y métodos se refierenparticularmente al uso de estimulantes de factores neurotroficos, como por ejemplo, AIT-082(neotrofina), en el tratamiento de la neuropatía glaucomatosa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11098398P | 1998-12-03 | 1998-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR022685A1 true AR022685A1 (es) | 2002-09-04 |
Family
ID=22335984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990106130A AR022685A1 (es) | 1998-12-03 | 1999-12-02 | Uso de estimulantes de factores neurotroficos para el tratamiento de enfermedades neurodegenerativas oftalmicas. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1135134B1 (es) |
JP (1) | JP2002531405A (es) |
KR (1) | KR100688137B1 (es) |
CN (1) | CN1325308A (es) |
AR (1) | AR022685A1 (es) |
AT (1) | ATE290866T1 (es) |
AU (1) | AU769290B2 (es) |
BR (1) | BR9915803A (es) |
CA (1) | CA2353527C (es) |
DE (1) | DE69924284T2 (es) |
ES (1) | ES2237196T3 (es) |
HK (1) | HK1038510B (es) |
PT (1) | PT1135134E (es) |
TW (1) | TWI246421B (es) |
WO (1) | WO2000032197A1 (es) |
ZA (1) | ZA200102714B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE499103T1 (de) | 2000-07-07 | 2011-03-15 | Spectrum Pharmaceuticals Inc | Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen |
US20020156277A1 (en) * | 2001-04-20 | 2002-10-24 | Fick David B. | Synthesis and methods of use of purine analogues and derivatives |
MXPA04001255A (es) * | 2001-08-29 | 2004-05-27 | Alcon Inc | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. |
US20060287246A1 (en) * | 2003-09-24 | 2006-12-21 | Shinji Yoneda | Remedy for eye diseases accompanied by optic nerve injuries |
JPWO2006054513A1 (ja) * | 2004-11-19 | 2008-05-29 | キッセイ薬品工業株式会社 | 神経因性疼痛の予防又は治療剤 |
EP1754474A1 (en) * | 2005-02-02 | 2007-02-21 | Eucro European Contract Research GmbH & Co. KG | Use of S-Clenbuterol |
EP2266559A1 (en) | 2005-03-15 | 2010-12-29 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for ophthalmic disease |
ES2588770T3 (es) | 2010-08-16 | 2016-11-04 | Santhera Pharmaceuticals (Schweiz) Ag | Derivados de benzoquinona para el tratamiento de enfermedades oculares mitocondriales |
CN104994845B (zh) * | 2012-10-23 | 2017-11-17 | 尼科斯科学爱尔兰公司 | 用于眼科应用的醌基一氧化氮供体化合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH059114A (ja) * | 1990-08-29 | 1993-01-19 | Takeda Chem Ind Ltd | 糖尿病性合併症の予防・治療剤 |
US5780450A (en) * | 1995-11-21 | 1998-07-14 | Alcon Laboratories, Inc. | Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
US6261545B1 (en) * | 1996-09-13 | 2001-07-17 | Advanced Medicine Research Institute | Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders |
WO1998010758A1 (en) * | 1996-09-13 | 1998-03-19 | The Regents Of The University Of California | Methods for treatment of retinal diseases |
JPH10218787A (ja) * | 1997-02-06 | 1998-08-18 | Akio Okamoto | 神経栄養因子による眼科用組成物 |
-
1999
- 1999-11-23 TW TW088120454A patent/TWI246421B/zh not_active IP Right Cessation
- 1999-12-01 CN CN99813086A patent/CN1325308A/zh active Pending
- 1999-12-01 EP EP99965071A patent/EP1135134B1/en not_active Expired - Lifetime
- 1999-12-01 CA CA002353527A patent/CA2353527C/en not_active Expired - Fee Related
- 1999-12-01 KR KR1020017003178A patent/KR100688137B1/ko not_active IP Right Cessation
- 1999-12-01 AT AT99965071T patent/ATE290866T1/de active
- 1999-12-01 BR BR9915803-5A patent/BR9915803A/pt not_active Application Discontinuation
- 1999-12-01 PT PT99965071T patent/PT1135134E/pt unknown
- 1999-12-01 AU AU31066/00A patent/AU769290B2/en not_active Ceased
- 1999-12-01 JP JP2000584892A patent/JP2002531405A/ja active Pending
- 1999-12-01 ES ES99965071T patent/ES2237196T3/es not_active Expired - Lifetime
- 1999-12-01 WO PCT/US1999/028385 patent/WO2000032197A1/en not_active Application Discontinuation
- 1999-12-01 DE DE69924284T patent/DE69924284T2/de not_active Expired - Lifetime
- 1999-12-02 AR ARP990106130A patent/AR022685A1/es unknown
-
2001
- 2001-04-03 ZA ZA200102714A patent/ZA200102714B/en unknown
-
2002
- 2002-01-08 HK HK02100111.2A patent/HK1038510B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU3106600A (en) | 2000-06-19 |
JP2002531405A (ja) | 2002-09-24 |
HK1038510B (zh) | 2005-05-20 |
KR100688137B1 (ko) | 2007-03-09 |
EP1135134B1 (en) | 2005-03-16 |
CN1325308A (zh) | 2001-12-05 |
ES2237196T3 (es) | 2005-07-16 |
KR20010075055A (ko) | 2001-08-09 |
ATE290866T1 (de) | 2005-04-15 |
ZA200102714B (en) | 2002-06-03 |
DE69924284D1 (de) | 2005-04-21 |
WO2000032197A1 (en) | 2000-06-08 |
TWI246421B (en) | 2006-01-01 |
CA2353527A1 (en) | 2000-06-08 |
CA2353527C (en) | 2007-11-06 |
PT1135134E (pt) | 2005-05-31 |
BR9915803A (pt) | 2001-08-21 |
EP1135134A1 (en) | 2001-09-26 |
DE69924284T2 (de) | 2005-08-04 |
AU769290B2 (en) | 2004-01-22 |
HK1038510A1 (en) | 2002-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020252397A8 (en) | Small molecule proteolysis-targeting chimeras and methods of use thereof | |
AR042097A1 (es) | Uso de de eritropoyetina para el tratamiento de los trastornos de l a distribucion de hierro en las enfermedades cardiacas | |
BR9611748A (pt) | Uso de um produto protéico de fator neurotrófico derivado de linhagem de célula glial | |
CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
MXPA06014470A (es) | Formulaciones oftalmicas que incluyen antagonistas de alfa 1 selectivas. | |
PA8432901A1 (es) | Compuestos de piridilpirrol | |
CR7511A (es) | Proceso para la preparacion de 3 quinolina 7 sustituida y 3- quinol-4-ona carbonitrilos | |
UY30058A1 (es) | (indazol-5-il)-piracinas y (1,3-dihidro-indol-2-on)-piracinas para el tratamiento de enfermedades y afecciones mediadas por la rho quinasa | |
DE60037578D1 (de) | Verwendung von triacetyluridin zur behandlung von mitochondrialen erkrankungen | |
MX9306133A (es) | Composicion que comprende una formulacion del factor de coagulacion viii, proceso para su preparacion y uso de un surfactante como estabilizador. | |
ES2172670T3 (es) | Pirrolpirimidinas y procedimientos para su preparacion. | |
ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
ES2186670T3 (es) | Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular. | |
AR029215A1 (es) | Derivados de benzazol y tautomeros de los mismos utiles en el tratamiento de desordenes en los sistemas de autoinmunidad y neuronales, uso de dichos derivados en la preparacion de composiciones farmaceuticas aplicables en el tratamiento de dichos desordenes, metodo prar inhibir la expresion y/o acti | |
ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
AR051472A1 (es) | Uso de inhibidores de las quinasas jun n- terminales para eltratamiento de la retinopatia glaucomatosa y enfermedades oculares | |
MX368377B (es) | Combinacion de brimonidina y timolol para uso oftalmico, topico. | |
ECSP055572A (es) | Derivados ciclotiocarbamativos como moduladores pr y el uso de los mismos en el tratamiento de enfermedades de la piel. | |
MX9305269A (es) | Utilizacion del receptor de il-4 para la terapia,la profilaxis y el diagnostico de enfermedades alergicas, viricas, parasitarias y bacterianas asi como de infecciones por hongos. | |
ES2134197T3 (es) | Vacunas contra el virus del herpes simplex vp16. | |
AR022685A1 (es) | Uso de estimulantes de factores neurotroficos para el tratamiento de enfermedades neurodegenerativas oftalmicas. | |
BRPI0417175A (pt) | composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas | |
BR9910288A (pt) | Uso de um corante vital para facilitar os procedimentos cirúrgicos para a cirurgia vìtreo-retinal | |
DOP2003000747A (es) | Composiciones oftalmicas para el tratamiento de la hipertension ocular | |
AR009028A1 (es) | Composiciones farmaceuticas, un procedimiento para preparar dichas composiciones y utilizacion de dichas composiciones en el tratamiento deenfermedades oftalmicas y metodos para tratar dichas enfermedades |